Danping Lou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Danping Lou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dan Li
Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
1 shared publication - Fangyou Yu
Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China
1 shared publication - Liangxing Wang
Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication - Longhua Hu
Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University
1 shared publication - Xiaoying Huang
Key Laboratory of Heart and Lung, Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
1 shared publication - Xueqing Zhang
Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, 2 Fuxue lane, Wenzhou 325000, China
1 shared publication
Latest Publications
- Open Access
- 5 December 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 282
First identification of coexistence of blaNDM-1 and blaCMY-42among Escherichia coli ST167 clinical isolates
Emergence of multidrug resistance in Enterobacteriaceae limits the selection of antimicrobials for treatment of infectious diseases. Identification of NDM-1 makes more difficulty in treating multidrug-resistant Enterobacteriaceae infections. Carbapenem-resistant Escherichia coli clinical isolates from a tertiary hospital in Wenzhou, east China, were investigated for NDM-1 production.
- 5 December 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 282
Open AccessFirst identification of coexistence of blaNDM-1 and blaCMY-42among Escherichia coli ST167 clinical isolates
Emergence of multidrug resistance in Enterobacteriaceae limits the selection of antimicrobials for treatment of infectious diseases. Identification of NDM-1 makes more difficulty in treating multidrug-resistant Enterobacteriaceae infections. Carbapenem-resistant Escherichia coli clinical isolates from a tertiary hospital in Wenzhou, east China, were investigated for NDM-1 production.